Xu, Qi
Xu, Xiaoqing
Tang, Haimeng
Yan, Junrong http://orcid.org/0000-0001-9750-7518
Li, Jingjing
Bao, Hua
Wu, Xue
Shao, Yang
Luo, Cong
Wen, Haimin
Jin, Jianying http://orcid.org/0000-0001-7748-1816
Ying, Jieer http://orcid.org/0000-0001-9452-1242
Article History
Received: 8 November 2022
Revised: 28 March 2023
Accepted: 30 March 2023
First Online: 18 April 2023
Competing interests
: Authors HT, JY, HB, XW, and YS are employed by Nanjing Geneseeq Technology Inc. The remaining authors declare no competing interests.
: This study was approved by the ethics committee of the Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital, Approval No. IRB-2022-70). All participants were informed of the intended research and consented to sample collection and publication usage.
: Consent for publication was obtained from each individual for their data to appear in this study.